As of 23 Oct 2026, Shukra Pharmaceuticals Ltd share price is ₹62.49. The stock opened at ₹62.49 and had closed at ₹68.48 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹26.30 and a high of ₹75.50. In terms of performance, Shukra Pharmaceuticals Ltd share price has increased by 100.80% over the past six months and has increased by 55.18% over the last year.
SHUKRAPHAR Stock Price Chart
Shukra Pharmaceuticals Ltd Overview
About SHUKRAPHAR
Shukra Pharmaceuticals is engaged in the manufacturing, marketing, and export of pharmaceutical formulations. The Company caters to both domestic and international markets, with a growing presence in countries such as Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen.
Shukra Pharmaceuticals Ltd Historical Performance
Shukra Pharmaceuticals Ltd Fundamentals
Shukra Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 61.29 | 36.80 | 77.39 | 60.03 | 20.57 |
| EBITDA | 33.30 | 16.93 | 22.22 | 6.56 | 2.97 |
| Net Profit | 22.05 | 9.58 | 18.54 | 4.41 | 0.75 |
| EPS | 0.50 | 0.22 | 16.93 | 11.23 | 4.79 |
Shukra Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 68.05 |
| Resistance 1 (R1) | 69.00 |
| Pivot Point | 68.57 |
Shukra Pharmaceuticals Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 21-Sep-2026 | 07-May-2026 | 21-Sep-2026 | Final | ₹0.01 |
| 18-Sep-2025 | 04-Jun-2025 | 18-Sep-2025 | Final | ₹0.01 |
| 23-Sep-2024 | 29-May-2024 | 24-Sep-2024 | Final | ₹1.00 |
| 15-Sep-2023 | 29-May-2023 | 16-Sep-2023 | Final | ₹0.50 |
| 22-Sep-2022 | 28-May-2022 | 22-Sep-2022 | Final | ₹0.50 |
SHUKRAPHAR Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Dakshesh Shah | Chairman & Managing Director |
| Payal Mehta | Executive Directorector |
| Dhruvin Shah | E D & Wholetime Directorector |
Shukra Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,758.00+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,162.00-0.30% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,615.30+1.35% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Shukra Pharmaceuticals Ltd today is ₹62.49 on NSE and ₹62.49 on BSE.
- The 52-week high of Shukra Pharmaceuticals Ltd is ₹75.50, while the 52-week low is ₹26.30.
- The current market capitalisation of Shukra Pharmaceuticals Ltd is approximately ₹2,765 crore.
- The P/E (Price-to-Earnings) ratio of Shukra Pharmaceuticals Ltd is 61.39. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Shukra Pharmaceuticals Ltd is 164.52. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Shukra Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for SHUKRAPHAR on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Shukra Pharmaceuticals Ltd has delivered a return of approximately 2665.04%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Shukra Pharmaceuticals Ltd comprises different categories of shareholders. As of Aug 2026, the shareholding is approximately 51.15% promoters, 0.00% FIIs, 0.11% DIIs, and 9.34% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
